[A&V]RWE部長

**BACKGROUND** The utilization of Real-World Data (RWD) is being recognized for its broad applications from drug discovery to post-marketing across various occasions, in the pharmaceutical industry. The Real-World Evidence (RWE) team within Access & Value leads end-to-end evidence generation—from strategy development to study planning and execution, through to publication—to optimize access for Pfizer products across all therapeutic areas. The RWE team has spearheaded numerous initiatives, promoting RWD use across Pfizer’s divisions and leading industry-wide discussions on the subject. We have also emerged as leaders in the field. To accommodate the growing demand for RWD analysis, we expanded our team in early 2023. To continue pioneering RWD utilization in the industry, it is essential to form a highly specialized, high-performing RWE team with a leadership role in managing the RWD/RWE division. **ROLE SUMMARY** Lead the sourcing, planning, interpretation, customization, generation, and dissemination of high-quality RWE promptly. This role directs and supports all functions for RWD sources and evidence generation, pertinent to all in-line and pipeline activities, while serving as an expert liaison with external stakeholders. **ROLE RESPONSIBILITIES** * Lead evidence generation for optimizing access of Pfizer products across all therapeutic areas from strategy development to study planning and execution, through to publication. * Establish RWD sources and analytic capabilities by partnering with key internal stakeholders on the development and operation of the Data Mart including Japanese RWD, and support RWD strategy development, planning, and execution, aligning with all global and local colleagues to close the data gap and demonstrate the value of products. * Lead and shape external discussions on RWD policy, methods, and processes as appropriately aligned to business categories and where possible, proactively input into professional consultation opportunities.